Subscribe to
Universal Health Services, Inc. (NYSE:UHS) is one of the most active losers as it plunges over 5.07% to $57.64 on huge volume of 1.65 million shares after the company reported higher quarterly net earnings on Thursday as revenue rose slightly, operating margins improved while costs were cut. Third-quarter net earnings were $51.07 million, or $1.03 per diluted share, in the third quarter, compared with $36.99 million, or 73 cents per diluted share, in the year-ago period.
Hemispherx BioPharma, Inc (AMEX:HEB) fell 6% to $1.41 on huge volume of 1.60 million shares. The stock has ranged from $0.26 to $4.54 over the past 52-weeks. So far the stock prices went up over 167% in last six months of trading sessions. Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
CEL-SCI Corporation (AMEX:CVM) slipped 4.67% to $1.02 on over 895K shares. The stock has ranged from $0.14 to $2.10 over the past 52-weeks. So far the stock prices went up over 206% in last six months of trading sessions. CEL-SCI Corporation is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day.